DENVER, CO / ACCESSWIRE / June 30, 2014 / In a teaming of two established and respected companies in the cannabis industry, CannLabs, Inc. (OTCQB: SDSPD) today announced the signing of a new 12-month exclusive national agreement to provide testing services for Dixie Elixirs and Edibles, one of America’s first revolutionaries in THC-infused edibles, topicals and tinctures.
“We are dedicated to helping companies ensure their cannabis products meet all mandated requirements for health and safety plus so much more including consulting,” said Genifer Murray, CEO of CannLabs. “Dixie is well-known for its outstanding products and has been testing with us for years, well before testing was mandated. They know that through testing with CannLabs, their customers can continue to be assured that what they purchase consistently meets the high quality standards Dixie has established.”
CannLabs, which is a leader in cannabis innovation, science and technology, is a trusted testing service for an ever-expanding base of clients. In addition to testing, the company offers real-time data analytics, product benchmarking capabilities, cultivation advice and education, and consulting and reformulation services.
“Testing has always been a cornerstone of our promise of quality and consistency to our customers,” said Tripp Keber, CEO of Dixie. “We are proud to be partnered with CannLabs in developing the critical science behind what will undoubtedly become a standard for other states and countries in the testing of edibles and concentrates.”
ABOUT CANNLABS
CannLabs, Inc., is a solutions provider with intellectual property, proprietary cloud-based analytics and scientific methods to serve the cannabis industry. Through Carbon Bond Holdings Inc., CannLabs provides laboratories with the necessary business intelligence technology and other solutions required to serve the cannabis industry, and these include the first state-licensed laboratory in Denver, Colorado.
CannLabs enables growers, dispensaries and edible makers to implement best practices while furthering product advancements. In addition, the CannLabs website allows consumers to easily locate certified tested products to meet their specific needs.
CannLabs has been at the forefront of educating the public, in addition to state and local governments as more states legalize marijuana for various uses. The Company provides client education around safe cultivation, identifying contamination problems, consulting on legal cases and the reformulation of cannabis products, throughout the U.S. and Canada.
The Company plans to license their solutions to new labs and other cannabis companies in states and provinces as legislation and testing mandates for legalization are approved.
This will allow the Company to further scale its data analytics and consulting business across a broader geographic area. In addition, the CannLabs team will focus on research and development which will further drive value for their customers and provide incremental revenue opportunity.
For more information visit http://www.cannlabs.com/.
ABOUT DIXIE ELIXIRS AND EDIBLES
Located in Denver, Colorado, Dixie Elixirs and Edibles (Dixie) has been producing award-winning THC-infused products since 2009. What began as a single flagship product, the Dixie Elixir (a THC-infused soda), has now expanded to over 30 different products across over 100 SKUs, representing the industry’s finest edibles, tinctures, topicals and connoisseur grade extractions. To find out more about Dixie’s innovative products, or about how Dixie is building the future of cannabis, please visit us at http://www.dixieelixirs.com/. Remember–you must be 21 to visit our site, as cannabis products are not for those under the age of 21!
Safe Harbor Statement
All statements herein other than statements of historical facts are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Such statements are not guarantees of future performance and are subject to known and unknown risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements. Such factors include, but are not limited to, our ability to raise additional capital, our limited operating history and revenue, our ability to attract and retain qualified personnel, our ability to develop new services, market acceptance of our services, legislative, regulatory and competitive developments in our industry, general economic conditions, as well as other factors set forth in our filings with the SEC.
CONTACT:
Company
Robert Farrell
Vice President of Marketing
855-842-6936
robert.farrell@cannlabs.com
http://www.cannlabs.com/
Investor Relations
Matt Hayden
Chairman
MZ North America
949-259-4986
matt.hayden@mzgroup.us
http://www.mzgroup.us/
Source: CannLabs, Inc.
The Wall Street Journal news department was not involved in the creation of this content.
( SDSPD ) CannLabs Signs Exclusive National Agreement with Dixie Elixirs
No comments:
Post a Comment